Atorvastatin & Clopidogrel Tablets – Otovas C Tablets

OTOVAS C Tablets
Composition:- Atorvastatin 40 mg

OTOVAS C Tablets – The dual combination of Atorvastatin & Clopidogrel Tablets provides a comprehensive approach to cardiovascular protection:
Atorvastatin – An HMG-CoA reductase inhibitor (statin) that lowers LDL cholesterol and triglycerides while increasing HDL cholesterol, helping to reduce the risk of atherosclerosis.
Clopidogrel – An antiplatelet agent that prevents blood clots by inhibiting platelet aggregation, reducing the chances of stroke and heart attack.

Key Points of Atorvastatin & Clopidogrel Tablets – OTOVAS C Tablets
• Dual Benefits for Heart Protection – Provides both cholesterol reduction and clot prevention, lowering the risk of heart attacks, strokes, and complications in high-risk patients.
• Broad Cardiovascular Risk Management – Atorvastatin reduces cholesterol and slows atherosclerosis progression, while Clopidogrel prevents clot formation in narrowed arteries for comprehensive protection.
• Proven Efficacy in High-Risk Groups – Clinical evidence supports significant reduction of major cardiovascular events in patients with heart disease or risk factors such as diabetes, hypertension, or smoking.

Can be Prescribed by:
• Cardiologists
• General Physicians
• Neurologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.